mucin glycopeptides prepared respiratory mucus chronic bronchitic patient blood group o lea oligosaccharides released alkaline borohydride treatment purified chromatography chromatography high performance chromatography structural studies employed 1hnmr spectroscopy matrix assisted laser mass spectrometry monosulfated oligosaccharides ranging size hexasaccharide fully characterized study sulfate group occurs terminal galactose residue residue keeping status patient structure alpha fucose residue structures fucose present alpha x determinant oligosaccharide compound 7b seen fucose alpha lea determinant structures isolated mucins patient previously respiratory mucins listed non secretor b anion exchange size exclusion anion exchange NUMBER mhz maldi ms tetra c NUMBER c NUMBER n acetylglucosamine non secretor NUMBER NUMBER linked NUMBER NUMBER linkage NUMBER NUMBER linked non secretor desorption ionization